Precipitation of hepatic encephalopathy by propranolol in cirrhosis.
作者信息
Tarver D, Walt R P, Dunk A A, Jenkins W J, Sherlock S
出版信息
Br Med J (Clin Res Ed). 1983 Aug 27;287(6392):585. doi: 10.1136/bmj.287.6392.585.
Abstract
摘要
相似文献
1
Precipitation of hepatic encephalopathy by propranolol in cirrhosis.肝硬化患者中普萘洛尔诱发肝性脑病
Br Med J (Clin Res Ed). 1983 Aug 27;287(6392):585. doi: 10.1136/bmj.287.6392.585.
2
Does propranolol precipitate hepatic encephalopathy?普萘洛尔会引发肝性脑病吗？
J Clin Gastroenterol. 1986 Feb;8(1):74-6. doi: 10.1097/00004836-198602000-00016.
3
KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications.《肝硬化的KASL临床实践指南：静脉曲张、肝性脑病及相关并发症》
Clin Mol Hepatol. 2020 Apr;26(2):83-127. doi: 10.3350/cmh.2019.0010n. Epub 2020 Jan 10.
4
Beta-adrenergic antagonists for primary prevention of gastrointestinal hemorrhage in patients with cirrhosis and esophageal varices.
Clin Pharm. 1992 Apr;11(4):337-41.
5
[Prevention of hemorrhage from esophageal varices in patients with liver cirrhosis by administration of propranolol].[通过给予普萘洛尔预防肝硬化患者食管静脉曲张出血]
Rev Gastroenterol Mex. 1986 Oct-Dec;51(4):187-90.
6
Propranolol in the primary prevention of upper gastrointestinal tract haemorrhage in patients with cirrhosis of the liver and oesophageal varices.普萘洛尔在肝硬化合并食管静脉曲张患者上消化道出血一级预防中的应用
Drugs. 1989;37 Suppl 2:52-61; discussion 74-6. doi: 10.2165/00003495-198900372-00011.
7
Preventing hemorrhage from esophageal varices.预防食管静脉曲张出血。
N Engl J Med. 1987 Oct 1;317(14):893-5. doi: 10.1056/NEJM198710013171409.
8
Oesophageal varices prior to bleeding. Diagnosis and physiological and therapeutic effects of propranolol in cirrhosis.
Dan Med Bull. 1993 Jun;40(3):306-16.
9
Variceal haemorrhage.静脉曲张出血
J R Coll Physicians Lond. 1973 Oct;8(1):75-8.
10
[The use of an animal liver in hepatic insufficiency in a patient with hemorrhage from the esophageal vein].
Khirurgiia (Mosk). 1967 Dec;43(12):84-6.
引用本文的文献
1
Drug administration in chronic liver disease.慢性肝病中的药物给药
Drug Saf. 1997 Jul;17(1):47-73. doi: 10.2165/00002018-199717010-00004.
2
Sclerotherapy versus sclerotherapy and propranolol in the prevention of rebleeding from oesophageal varices: a randomised study.硬化疗法与硬化疗法联合普萘洛尔预防食管静脉曲张再出血的随机对照研究
Gut. 1996 May;38(5):770-4. doi: 10.1136/gut.38.5.770.
3
Endoscopic variceal pressure measurements: response to isosorbide dinitrate.内镜下静脉曲张压力测量：对硝酸异山梨酯的反应
Gut. 1985 Aug;26(8):843-7. doi: 10.1136/gut.26.8.843.
4
Pharmacology of propranolol in patients with cirrhosis and portal hypertension.心得安在肝硬化和门静脉高压患者中的药理学研究。
Gut. 1985 Jan;26(1):14-9. doi: 10.1136/gut.26.1.14.
5
Effect of nadolol on liver haemodynamics and function in patients with cirrhosis.纳多洛尔对肝硬化患者肝脏血流动力学及功能的影响。
Br J Clin Pharmacol. 1986 Jun;21(6):713-9. doi: 10.1111/j.1365-2125.1986.tb05237.x.
6
Long-term effect of nadolol on quantitative liver function tests in patients with cirrhosis.
Eur J Clin Pharmacol. 1988;34(5):501-4. doi: 10.1007/BF01046709.
7
Prophylaxis of first variceal hemorrhage in patients with liver cirrhosis.肝硬化患者首次静脉曲张出血的预防
Klin Wochenschr. 1986 Dec 15;64(24):1267-75. doi: 10.1007/BF01785707.
8
Safety of propranolol in portal hypertension. Conventional and long acting formulations.
Drugs. 1989;37 Suppl 2:70-3; discussion 74-6. doi: 10.2165/00003495-198900372-00013.
本文引用的文献
1
Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study.普萘洛尔预防肝硬化患者复发性胃肠道出血的对照研究。
N Engl J Med. 1981 Dec 3;305(23):1371-4. doi: 10.1056/NEJM198112033052302.
2
Propranolol--a medical treatment for portal hypertension?普萘洛尔——一种治疗门静脉高压症的药物？
Lancet. 1980 Jul 26;2(8187):180-2. doi: 10.1016/s0140-6736(80)90063-x.
Zotero 插件